Dr Anthony Williams joins Neotropix
This article was originally published in Scrip
Neotropix, a US clinical-stage development company focused in neuroendocrine cancer treatments, has named Dr Anthony Williams chief medical officer. Dr Williams has more than 25 years' drug development experience, having previously served as vice-president of medical research at Synta Pharmaceuticals. He has also worked at GlaxoSmithKline, Merrell Dow and Dyax.